Threatened Abortion Clinical Trial
Official title:
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion: a Randomized, Double-blinded, Placebo-controlled Trial
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02420769 -
Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion
|
N/A | |
Withdrawn |
NCT01501890 -
Progesterone for First Trimester Vaginal Bleeding
|
N/A | |
Completed |
NCT02686112 -
Pregnancy Outcome in Woman With Threatened Abortion
|
N/A | |
Completed |
NCT03930212 -
Progesterone Supplementation in Threatened Abortion
|
Phase 4 |